-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Topics
Meeting category
Date(s)
23 Oct 2022
Location
Glasgow,
United Kingdom
Meeting type
Hybrid Meeting
Organizer
HIV Glasgow 2022 Symposium - The Devil Wears GP120
Related Enduring Materials
Enduring Materials
23 October 2022 -
Immune Dysregulation – a Remaining Challenge in HIV Medicine
Clinical Data from the GP120 Inhibitor Temsavir and its Relevance to Immune Reconstitution and HIV Associated Inflammation
Temsavir Blocks HIV-1 Soluble GP120-induced Immunomodulatory Activities
General
What's New
Image
About the Program
HIV pathogenesis remains an intriguing but not fully understood phenomenon. Although great strides have been made in the last 30 years, much remains to be discovered. GP120 plays a major role in HIV binding to target cells, but recent studies suggest GP120 may play a much greater role in HIV interactions with the immune system. An improved understanding of these interactions may help overcome some of the remaining unmet needs of people living with HIV.
One such example might be improving the immune reconstitution of patients with poor or partial CD4 responses to suppressive therapy. Although CD4 cells and CD4/CD8 ratios improve in most patients after HIV RNA suppression is maintained, these responses can be blunted in highly treatment experienced patients of those starting therapy with very low CD4 counts. GP 120 may be playing a role in these patients, and its inhibition might provide clinical benefit. Additional negative GP120 effects on immune and inflammatory responses might be favorably manipulated with drugs targeting this molecule. This program aims to educate clinicians on recent advances in the study of GP120, and review both basic science as well as clinical data relevant to the topic.
Program Director
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the HIV Glasgow 2022 Symposium - The Devil Wears GP120 will be held as a hybrid meeting. The meeting will be held in Glasgow, United Kingdom, and also offers the opportunity to participate virtually.
By merging in-person communication and virtual elements, the hybrid meeting format is an optimal solution in light of the current circumstances. The Conference Organizers will continue to observe the ongoing COVID-19 pandemic and will take necessary steps to ensure that the meeting will be held in compliance with relevant regulations, prioritizing the health and safety of our participants.
We are available to answer any questions or concerns that you may have about your participation at the HIV Glasgow 2022 Symposium - The Devil Wears GP120. For more information, please contact Ms Yee Ning Tham at yeening.tham@amededu.com.
To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
By merging in-person communication and virtual elements, the hybrid meeting format is an optimal solution in light of the current circumstances. The Conference Organizers will continue to observe the ongoing COVID-19 pandemic and will take necessary steps to ensure that the meeting will be held in compliance with relevant regulations, prioritizing the health and safety of our participants.
We are available to answer any questions or concerns that you may have about your participation at the HIV Glasgow 2022 Symposium - The Devil Wears GP120. For more information, please contact Ms Yee Ning Tham at yeening.tham@amededu.com.
To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
Who Should Attend?
- HIV physicians experienced in treating treatment-experienced HIV patients who need to be informed and updated on new treatment options;
- HIV physicians inexperienced in treating complex HIV patients who need a more comprehensive education on identifying and managing treatment-experienced patients with an emphasis on new drugs;
- Other healthcare professionals (e.g., nurse practitioners) intimately involved in the medical care of treatment-experienced patients.
- HIV physicians inexperienced in treating complex HIV patients who need a more comprehensive education on identifying and managing treatment-experienced patients with an emphasis on new drugs;
- Other healthcare professionals (e.g., nurse practitioners) intimately involved in the medical care of treatment-experienced patients.
Learning Objectives
After participating at this educational activity, participants will be able to:
- Have improved knowledge of recent advances in the study of GP120 in HIV pathogenesis;
- Understand the potential for clinical benefits from inhibition of GP120 regarding immune reconstitution and anti-inflammation;
- Be knowledgeable of the current laboratory and clinical data supporting these concepts.
- Have improved knowledge of recent advances in the study of GP120 in HIV pathogenesis;
- Understand the potential for clinical benefits from inhibition of GP120 regarding immune reconstitution and anti-inflammation;
- Be knowledgeable of the current laboratory and clinical data supporting these concepts.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the meeting is English
Conference Materials
Conference materials can be obtained upon registration at meeting room on the meeting day. An official program and speakers' bios will be sent by e-mail to our virtual attendees one day prior to the meeting.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Committees
Program Director
Support
The HIV Glasgow 2022 Symposium - The Devil Wears GP120 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Accreditation
EACCME® Accreditation
The HIV Glasgow 2022 Symposium - The Devil Wears GP120, Glasgow, Scotland, United Kingdom, 23/10/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
COVID-19
Health & Safety Measures regarding COVID-19
Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organised by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.
National Health & Safety Measures
The health and safety measures that will be taken by Virology Education during theHIV Glasgow 2022 Symposium - The Devil Wears GP120 are listed on the government website of the United Kingdom. Please read them very carefully before travelling to the conference venue.
Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at yeening.tham@amededu.com.
Traveling to the United Kingdom
Virology Education strongly advises participants to check the government website of the United Kingdom for the latest and most accurate information about the rules regarding travel.
Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc.
What if I get ill during the event?
Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.
